Finansiella nyckeltal Veeva Systems Inc.
Aktier
VEEV
US9224751084
Avancerad medicinsk utrustning & teknologi
Realtidsuppskattning
Andra börsplatser
|
5-dagars förändring | Förändring 1 jan. | ||
226,47 USD | −0,44 % | −0,02 % | +17,83 % |
25.11. | Veeva Systems lanserar Vault CRM Bot och Vault CRM Voice Control, två nya GenAI-funktioner i Vault CRM | CI |
14.11. | Boehringer Ingelheim väljer Veeva Vault CRM | CI |
Skatteperiod: Januari | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Lönsamhet | ||||||||||
Return on Assets | 9,16 | 8,88 | 9,21 | 6,66 | 5,01 | |||||
Return on Total Capital | 12,15 | 11,66 | 11,93 | 8,51 | 6,33 | |||||
Return On Equity % | 20,74 | 19,33 | 16,51 | 14,72 | 12,58 | |||||
Return on Common Equity | 20,74 | 19,33 | 16,51 | 14,72 | 12,58 | |||||
Marginalanalys | ||||||||||
Gross Profit Margin % | 72,52 | 72,09 | 72,79 | 71,72 | 71,35 | |||||
SG&A Margin | 27,47 | 26,22 | 24,83 | 26,28 | 26,57 | |||||
EBITDA Margin % | 27,84 | 27,8 | 28,8 | 22,65 | 19,54 | |||||
EBITA Margin % | 26,96 | 27,15 | 28,34 | 22,18 | 18,97 | |||||
EBIT Margin % | 26,04 | 25,79 | 27,31 | 21,3 | 18,16 | |||||
Income From Continuing Operations Margin % | 27,27 | 25,94 | 23,09 | 22,63 | 22,24 | |||||
Net Income Margin % | 27,27 | 25,94 | 23,09 | 22,63 | 22,24 | |||||
Net Avail. For Common Margin % | 27,27 | 25,94 | 23,09 | 22,63 | 22,24 | |||||
Normalized Net Income Margin | 17,66 | 16,94 | 17,54 | 14,68 | 14,89 | |||||
Levered Free Cash Flow Margin | 33,57 | 28,86 | 34,12 | 32,79 | 31,81 | |||||
Unlevered Free Cash Flow Margin | 33,57 | 28,86 | 34,12 | 32,79 | 31,81 | |||||
Tillgångsomslutning | ||||||||||
Asset Turnover | 0,56 | 0,55 | 0,54 | 0,5 | 0,44 | |||||
Fixed Assets Turnover | 13,9 | 13,66 | 17,24 | 20,59 | 22,59 | |||||
Receivables Turnover (Average Receivables) | 2,97 | 2,83 | 2,83 | 2,91 | 2,82 | |||||
Kortfristig likviditet | ||||||||||
Current Ratio | 2,78 | 3,23 | 3,7 | 3,94 | 4,24 | |||||
Quick Ratio | 2,74 | 3,18 | 3,65 | 3,86 | 4,17 | |||||
Operating Cash Flow to Current Liabilities | 0,79 | 0,77 | 0,91 | 0,78 | 0,77 | |||||
Days Sales Outstanding (Average Receivables) | 123 | 129,17 | 128,78 | 125,3 | 129,23 | |||||
Average Days Payable Outstanding | 17,16 | 19,1 | 15,8 | 18,57 | 19,72 | |||||
Långsiktig solvens | ||||||||||
Total Debt/Equity | 3,29 | 2,78 | 1,87 | 1,64 | 1,2 | |||||
Total Debt / Total Capital | 3,19 | 2,71 | 1,84 | 1,61 | 1,19 | |||||
LT Debt/Equity | 2,69 | 2,27 | 1,5 | 1,34 | 1 | |||||
Long-Term Debt / Total Capital | 2,6 | 2,21 | 1,47 | 1,31 | 0,99 | |||||
Total Liabilities / Total Assets | 26,68 | 25,6 | 23,71 | 22,65 | 21,42 | |||||
Total Debt / EBITDA | 0,17 | 0,15 | 0,1 | 0,12 | 0,12 | |||||
Net Debt / EBITDA | −3,27 | −3,81 | −4,24 | −6,03 | −8,31 | |||||
Total Debt / (EBITDA - Capex) | 0,18 | 0,15 | 0,1 | 0,12 | 0,12 | |||||
Net Debt / (EBITDA - Capex) | −3,3 | −3,89 | −4,36 | −6,2 | −8,79 | |||||
Tillväxt jämfört med föregående år | ||||||||||
Total Revenues, 1 Yr. Growth % | 28,05 | 32,7 | 26,33 | 16,44 | 9,68 | |||||
Gross Profit, 1 Yr. Growth % | 29,79 | 31,9 | 27,55 | 14,74 | 9,1 | |||||
EBITDA, 1 Yr. Growth % | 29,73 | 33,05 | 30,86 | −8,39 | −5,38 | |||||
EBITA, 1 Yr. Growth % | 29,47 | 34,29 | 31,85 | −8,85 | −6,22 | |||||
EBIT, 1 Yr. Growth % | 29,01 | 31,99 | 33,8 | −9,18 | −6,48 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 31,02 | 26,2 | 12,47 | 14,11 | 7,79 | |||||
Net Income, 1 Yr. Growth % | 31,02 | 26,2 | 12,47 | 14,11 | 7,79 | |||||
Normalized Net Income, 1 Yr. Growth % | 32,12 | 27,8 | 30,83 | −2,58 | 11,28 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 29,25 | 24,21 | 11,44 | 14,07 | 7,33 | |||||
Accounts Receivable, 1 Yr. Growth % | 31,38 | 44,75 | 13,54 | 13,08 | 13,16 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 89 | 6,43 | −5,82 | 0,98 | −0,97 | |||||
Total Assets, 1 Yr. Growth % | 37,37 | 34,08 | 25,29 | 25,88 | 23,03 | |||||
Tangible Book Value, 1 Yr. Growth % | −2,23 | 57,05 | 38,13 | 34,77 | 29,68 | |||||
Common Equity, 1 Yr. Growth % | 34,57 | 36,07 | 28,47 | 27,63 | 24,99 | |||||
Cash From Operations, 1 Yr. Growth % | 40,71 | 26,04 | 38,68 | 2,09 | 16,77 | |||||
Capital Expenditures, 1 Yr. Growth % | −63,12 | 100,95 | 63,7 | −4,94 | 93,87 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 54,19 | 14,32 | 49,37 | 11,89 | 6,41 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 54,19 | 14,32 | 49,37 | 11,89 | 6,41 | |||||
Sammansatt Årlig Tillväxthastighet Över Två År | ||||||||||
Total Revenues, 2 Yr. CAGR % | 26,44 | 30,35 | 29,47 | 21,28 | 13,01 | |||||
Gross Profit, 2 Yr. CAGR % | 29,27 | 30,84 | 29,71 | 20,97 | 11,89 | |||||
EBITDA, 2 Yr. CAGR % | 33,6 | 31,1 | 31,95 | 9,49 | −6,9 | |||||
EBITA, 2 Yr. CAGR % | 34,01 | 31,55 | 33,07 | 9,63 | −7,55 | |||||
EBIT, 2 Yr. CAGR % | 34,93 | 30,2 | 32,9 | 10,24 | −7,84 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 41,13 | 28,58 | 19,14 | 13,29 | 10,91 | |||||
Net Income, 2 Yr. CAGR % | 41,13 | 28,58 | 19,14 | 13,29 | 10,91 | |||||
Normalized Net Income, 2 Yr. CAGR % | 36,48 | 29,67 | 29,31 | 12,9 | 4,12 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % |